Global Engineered T Cells Market Analysis 2016-2020 and Forecast 2021-2027

  • Published Date : 26-08-2021
  • Pages : 97
  • Report Id : 53790
  • Categories : Healthcare

Snapshot

The global Engineered T Cells market size is estimated at xxx million USD with a CAGR xx% from 2016-2021 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2027. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Engineered T Cells by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor (CAR)

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Cancer Research Centers
Clinics

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 Engineered T Cells Industry
Figure Engineered T Cells Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Engineered T Cells
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Engineered T Cells
1.2.2 Downstream
Table Application Segment of Engineered T Cells
Table Global Engineered T Cells Market 2016-2027, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Engineered T Cells Market by Type
3.1 By Type
3.1.1 Tumor Infiltrating Lymphocytes
Table Major Company List of Tumor Infiltrating Lymphocytes
3.1.2 T Cell Receptor {TCR}
Table Major Company List of T Cell Receptor {TCR}
3.1.3 Chimeric Antigen Receptor (CAR)
Table Major Company List of Chimeric Antigen Receptor (CAR)
3.2 Market Size
Table Global Engineered T Cells Market 2016-2021, by Type, in USD Million
Figure Global Engineered T Cells Market Growth 2016-2021, by Type, in USD Million
Table Global Engineered T Cells Market 2016-2021, by Type, in Volume
Figure Global Engineered T Cells Market Growth 2016-2021, by Type, in Volume
3.3 Market Forecast
Table Global Engineered T Cells Market Forecast 2021-2027, by Type, in USD Million
Table Global Engineered T Cells Market Forecast 2021-2027, by Type, in Volume
4 Major Companies List
4.1 Autolus Limited (Company Profile, Sales Data etc.)
4.1.1 Autolus Limited Profile
Table Autolus Limited Overview List
4.1.2 Autolus Limited Products & Services
4.1.3 Autolus Limited Business Operation Conditions
Table Business Operation of Autolus Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Bellicum Pharmaceuticals (Company Profile, Sales Data etc.)
4.2.1 Bellicum Pharmaceuticals Profile
Table Bellicum Pharmaceuticals Overview List
4.2.2 Bellicum Pharmaceuticals Products & Services
4.2.3 Bellicum Pharmaceuticals Business Operation Conditions
Table Business Operation of Bellicum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Cells Medica (Company Profile, Sales Data etc.)
4.3.1 Cells Medica Profile
Table Cells Medica Overview List
4.3.2 Cells Medica Products & Services
4.3.3 Cells Medica Business Operation Conditions
Table Business Operation of Cells Medica (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Elli Lilly and Company (Company Profile, Sales Data etc.)
4.4.1 Elli Lilly and Company Profile
Table Elli Lilly and Company Overview List
4.4.2 Elli Lilly and Company Products & Services
4.4.3 Elli Lilly and Company Business Operation Conditions
Table Business Operation of Elli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Gilead Sciences (Company Profile, Sales Data etc.)
4.5.1 Gilead Sciences Profile
Table Gilead Sciences Overview List
4.5.2 Gilead Sciences Products & Services
4.5.3 Gilead Sciences Business Operation Conditions
Table Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Juno Therapeutics (Company Profile, Sales Data etc.)
4.6.1 Juno Therapeutics Profile
Table Juno Therapeutics Overview List
4.6.2 Juno Therapeutics Products & Services
4.6.3 Juno Therapeutics Business Operation Conditions
Table Business Operation of Juno Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Novartis (Company Profile, Sales Data etc.)
4.7.1 Novartis Profile
Table Novartis Overview List
4.7.2 Novartis Products & Services
4.7.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Oxford Biomedica (Company Profile, Sales Data etc.)
4.8.1 Oxford Biomedica Profile
Table Oxford Biomedica Overview List
4.8.2 Oxford Biomedica Products & Services
4.8.3 Oxford Biomedica Business Operation Conditions
Table Business Operation of Oxford Biomedica (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Pfizer (Company Profile, Sales Data etc.)
4.9.1 Pfizer Profile
Table Pfizer Overview List
4.9.2 Pfizer Products & Services
4.9.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Precision Bioscience (Company Profile, Sales Data etc.)
4.10.1 Precision Bioscience Profile
Table Precision Bioscience Overview List
4.10.2 Precision Bioscience Products & Services
4.10.3 Precision Bioscience Business Operation Conditions
Table Business Operation of Precision Bioscience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Redmile Group (Company Profile, Sales Data etc.)
4.11.1 Redmile Group Profile
Table Redmile Group Overview List
4.11.2 Redmile Group Products & Services
4.11.3 Redmile Group Business Operation Conditions
Table Business Operation of Redmile Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Seeking Alpha (Company Profile, Sales Data etc.)
4.12.1 Seeking Alpha Profile
Table Seeking Alpha Overview List
4.12.2 Seeking Alpha Products & Services
4.12.3 Seeking Alpha Business Operation Conditions
Table Business Operation of Seeking Alpha (Sales Revenue, Cost, Gross Margin)
4.13 Unum Therapeutics (Company Profile, Sales Data etc.)
4.13.1 Unum Therapeutics Profile
Table Unum Therapeutics Overview List
4.13.2 Unum Therapeutics Products & Services
4.13.3 Unum Therapeutics Business Operation Conditions
Table Business Operation of Unum Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Engineered T Cells Sales Revenue 2016-2021, by Company, in USD Million
Table Global Engineered T Cells Sales Revenue Share 2016-2021, by Company, in USD Million
Figure Global Engineered T Cells Sales Revenue Share in 2021, by Company, in USD Million
Table Global Engineered T Cells Sales Volume 2016-2021, by Company, in Volume
Table Global Engineered T Cells Sales Volume Share 2016-2021, by Company, in Volume
Figure Global Engineered T Cells Sales Volume Share in 2021, by Company, in Volume
5.2 Regional Market by Company
Figure North America Engineered T Cells Market Concentration, in 2021
Figure Europe Engineered T Cells Market Market Concentration, in 2021
Figure Asia-Pacific Engineered T Cells MMarket Concentration, in 2021
Figure South America Engineered T Cells Market Concentration, in 2021
Figure Middle East & Africa Engineered T Cells Market Concentration, in 2021
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Engineered T Cells Demand in Hospitals, 2016-2021, in USD Million
Figure Engineered T Cells Demand in Hospitals, 2016-2021, in Volume
6.1.2 Demand in Cancer Research Centers
Figure Engineered T Cells Demand in Cancer Research Centers, 2016-2021, in USD Million
Figure Engineered T Cells Demand in Cancer Research Centers, 2016-2021, in Volume
6.1.3 Demand in Clinics
Figure Engineered T Cells Demand in Clinics, 2016-2021, in USD Million
Figure Engineered T Cells Demand in Clinics, 2016-2021, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Engineered T Cells Demand Forecast 2021-2027, by Application, in USD Million
Figure Engineered T Cells Market Growth 2021-2027, by Application, in USD Million
Figure Engineered T Cells Market Share in 2027, by Application, in USD Million
Table Engineered T Cells Demand Forecast 2021-2027, by Application, in Volume
Table Engineered T Cells Market Growth 2021-2027, by Application, in Volume
Table Engineered T Cells Market Share in 2027, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Engineered T Cells Production 2016-2021, by Region, in USD Million
Table Engineered T Cells Production 2016-2021, by Region, in Volume
7.2 Regional Market
Table Global Engineered T Cells Market 2016-2021, by Region, in USD Million
Table Global Engineered T Cells Market Share 2016-2021, by Region, in USD Million
Table Global Engineered T Cells Market 2016-2021, by Region, in Volume
Table Global Engineered T Cells Market Share 2016-2021, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Engineered T Cells Market Size and Growth 2016-2021, in USD Million
Figure North America Engineered T Cells Market Size and Growth 2016-2021, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Engineered T Cells Market Size 2016-2021, by Country, in USD Million
Table North America Engineered T Cells Market Size 2016-2021, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Engineered T Cells Market Size and Growth 2016-2021, in USD Million
Figure Europe Engineered T Cells Market Size and Growth 2016-2021, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Engineered T Cells Market Size 2016-2021, by Country, in USD Million
Table Europe Engineered T Cells Market Size 2016-2021, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Engineered T Cells Market Size and Growth 2016-2021, in USD Million
Figure Asia-Pacific Engineered T Cells Market Size and Growth 2016-2021, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Engineered T Cells Market Size 2016-2021, by Country, in USD Million
Table Asia-Pacific Engineered T Cells Market Size 2016-2021, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Engineered T Cells Market Size and Growth 2016-2021, in USD Million
Figure South America Engineered T Cells Market Size and Growth 2016-2021, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Engineered T Cells Market Size 2016-2021, by Country, in USD Million
Table South America Engineered T Cells Market Size 2016-2021, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Engineered T Cells Market Size and Growth 2016-2021, in USD Million
Figure Middle East & Africa Engineered T Cells Market Size and Growth 2016-2021, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Engineered T Cells Market Size 2016-2021, by Country, in USD Million
Table Middle East & Africa Engineered T Cells Market Size 2016-2021, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Engineered T Cells Market Forecast 2021-2027, by Region, in USD Million
Table Engineered T Cells Market Forecast 2021-2027, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Research Allied Copyright © 2022 .